ArticleJournal of cardiology cases2025
Use of antibiotic loaded absorbable calcium beads in the treatment of infective endocarditis: A case report.
Article in Journal of cardiology cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infective endocarditis in drug-addicted patients is a clinical condition affected by high morbidity and mortality. Valvular lesions are often destructive and can lead to cardiogenic shock for which urgent surgery is necessary before an adequate period of antibiotic therapy. Here we report the case of a 49-year-old man known for drug abuse and referred for urgent surgery due to aortic endocarditis associated with an aortic root abscess. The patient underwent aortic valve replacement. The aortic abscess was excluded using a heterologous pericardial patch after filling with an antimicrobial carrier based on a matrix of calcium sulfate (Stimulan®; Biocomposites Ltd., Keele, UK). The patient had an uneventful postoperative course and recovered well at 6-month follow-up. To our knowledge, this is the first report demonstrating the safety and feasibility of Stimulan® use in the setting of cardiac surgery and infective endocarditis. Learning objective: Infective endocarditis surgery may benefit from the use of an on-site antibiotic carrier, especially when surgery is urgent, and an extended period of systemic treatment is not feasible. Drawing upon the expertise acquired from orthopedic surgery, the use of a topical antibiotic in a slow-release formulation can be safely deployed at the site of infection, close to a prosthetic aortic valve.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.